Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20020025941A1
SERIAL NO

09880038

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a combination product comprising at least one nucleic acid containing a sequence encoding a polypeptide or interest and at least one phospholipid of interest, for use which is simultaneous, consecutive or spread out over time, characterized in that said polypeptide and phospholipid of interest have cytotoxic activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRANSGENE S AILLKIRCH GRAFFENSTADEN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Meyer, Olivier Kirchheim, FR 13 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation